Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis. | Front Oncol | 2022 | 36119470 | PubTator, text mining | PubMed |
| Role of Exosomes in Pharyngucutaneous Fistula After Total Laryngectomy. | Int J Nanomedicine | 2022 | 36118178 | PubTator, text mining | PubMed |
| Composition, Biogenesis, and Role of Exosomes in Tumor Development. | Stem Cells Int | 2022 | 36117723 | PubTator, text mining | PubMed |
| N-glycosylation of CD82 at Asn157 is required for suppressing migration and invasion by reversing EMT via Wnt/β-catenin pathway in colon cancer. | Biochem Biophys Res Commun | 2022 | 36116374 | PubTator, text mining | PubMed |
| Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications. | J Exp Clin Cancer Res | 2022 | 36114510 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. | Mol Cancer | 2022 | 36100944 | PubTator, text mining | PubMed |
| The regulatory role of exosomes in venous thromboembolism. | Front Cell Dev Biol | 2022 | 36092737 | PubTator, text mining | PubMed |
| Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology. | Mol Ther Methods Clin Dev | 2022 | 36092361 | PubTator, text mining | PubMed |
| TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM. | Front Mol Biosci | 2022 | 36081847 | PubTator, text mining | PubMed |
| Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17. | Cells | 2022 | 36078095 | PubTator, text mining | PubMed |
| Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine. | Front Endocrinol (Lausanne) | 2022 | 36072925 | PubTator, text mining | PubMed |
| Crystal structure and fluorescence of 1-[8-phenyl-9-(phenyl-ethyn-yl)-4H-benzo[def]carbazol-4-yl]ethan-1-one. | Acta Crystallogr E Crystallogr Commun | 2022 | 36072156 | PubTator, text mining | PubMed |
| Isolation and structural comparison of RuII-dnp complexes [dnp = 2,6-bis-(1,8-naphthyridin-2-yl)pyridine] with axially or equatorially coordinating NCS ligands. | Acta Crystallogr E Crystallogr Commun | 2022 | 36072152 | PubTator, text mining | PubMed |
| Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models. | Drug Deliv | 2022 | 36068970 | PubTator, text mining | PubMed |
| Lung- and liver-dominant phenotypes of Korean eight constitution medicine have different profiles of genotype associated with each organ function. | Physiol Rep | 2022 | 36065883 | PubTator, text mining | PubMed |
| Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. | Nat Cancer | 2022 | 36065066 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| Nasal Staphylococcus aureus and S. pseudintermedius carriage in healthy dogs and cats: a systematic review of their antibiotic resistance, virulence and genetic lineages of zoonotic relevance. | J Appl Microbiol | 2022 | 36063061 | PubTator, text mining | PubMed |
| KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma. | Dis Markers | 2022 | 36046379 | PubTator, text mining | PubMed |
| Exosome-mediated effects and applications in inflammatory diseases of the digestive system. | Eur J Med Res | 2022 | 36045437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=35